References
- Casarin RCV, Salmon CR, Stolf CS et al. (2023) Salivary annexin A1: a candidate biomarker for periodontitis. J Clin Periodontol 50:942–951.
https://doi.org/10.1111/jcpe.13803 - Chen H, Gan X, Li Y et al. (2020) NLRP12- and NLRC4-mediated corneal epithelial pyroptosis is driven by GSDMD cleavage accompanied by IL-33 processing in dry eye. Ocul Surf 18:783–794.
https://doi.org/10.1016/j.jtos.2020.07.001 - Chen M, Rong R, Xia X (2022) Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases. J Neuroinflammation 19:183.
https://doi.org/10.1186/s12974-022-02547-2 - Fernandez-Torres MA, Lledó VE, Perez de Lara MJ et al. (2022) Effects of hyperosmolarity on annexin A1 on ocular surface epithelium in vitro. Exp Eye Res 224:109245.
https://doi.org/10.1016/j.exer.2022.109245 - Foo SL, Yap G, Cui J et al. (2019) Annexin-A1 – a blessing or a curse in cancer? Trends Mol Med 25:315–327.
https://doi.org/10.1016/j.molmed.2019.02.004 - Hakim FE, Farooq AV (2022) Dry eye disease: an update in 2022. JAMA 327:478–479.
https://doi.org/10.1001/jama.2021.19963 - Irie M, Kabata H, Sasahara K et al. (2023) Annexin A1 is a cell-intrinsic metalloregulator of zinc in human ILC2s. Cell Rep 42:112610.
https://doi.org/10.1016/j.celrep.2023.112610 - Jackson CJ, Gundersen KG, Tong L et al. (2022) Dry eye disease and proteomics. Ocul Surf 24:119–128.
https://doi.org/10.1016/j.jtos.2022.03.001 - Li S, Lu Z, Huang Y et al. (2022b) Anti-oxidative and anti-inflammatory micelles: break the dry eye vicious cycle. Adv Sci (Weinh) 9:e2200435.
https://doi.org/10.1002/advs.202200435 - Li C, Ma J, Mali N et al. (2022a) Relevance of the pyroptosis-related inflammasome drug targets in the Chuanxiong to improve diabetic nephropathy. Mol Med 28:136.
https://doi.org/10.1186/s10020-022-00567-5 - Luan Y, Luan Y, Jiao Y et al. (2023) Broadening horizons: exploring mtDAMPs as a mechanism and potential intervention target in cardiovascular diseases. Aging Dis 15:2395–2416.
https://doi.org/10.14336/AD.2023.1130 - Ren K, Pei J, Guo Y et al. (2023) Regulated necrosis pathways: a potential target for ischemic stroke. Burns Trauma 11:tkad016.
https://doi.org/10.1093/burnst/tkad016 - Safir M, Twig G, Mimouni M (2024) Dry eye disease management. BMJ 384:e077344.
https://doi.org/10.1136/bmj-2023-077344 - Singh S, Basu S, Geerling G (2022) Salivary gland transplantation for dry eye disease: indications, techniques, and outcomes. Ocul Surf 26:53–62.
https://doi.org/10.1016/j.jtos.2022.07.013 - Stapleton F, Velez FG, Lau C et al. (2024) Dry eye disease in the young: a narrative review. Ocul Surf 31:11–20.
https://doi.org/10.1016/j.jtos.2023.12.001 - Wu L, Liu C, Chang DY et al. (2021) Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy. Kidney Int 100:107–121.
https://doi.org/10.1016/j.kint.2021.02.025 - Xu X, Gao W, Li L et al. (2021) Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway. J Neuroinflammation 18:119.
https://doi.org/10.1186/s12974-021-02174-3 - Yang H, Liu D, Wang Y (2023) Physalin A exerts neuroprotective effects: inhibition of OGD/R-induced cellular pyroptosis and inflammatory responses in nerve cells. Signa Vitae 19:168–174.
https://doi.org/10.22514/sv.2023.111 - Yao Y, Yin Y, Shuai F et al. (2025) M2 macrophage-derived extracellular vesicles reprogram immature neutrophils into Anxa1hi neutrophils to enhance inflamed bone regeneration. Adv Sci 25:e2416159.
https://doi.org/10.1002/advs.202416159 - You Q, Ke Y, Chen X et al. (2024) Loss of endothelial annexin A1 aggravates inflammation-induched vascular aging. Adv Sci (Weinh) 11:e2307040.
https://doi.org/10.1002/advs.202307040 - Zhang Z, Zhang L, Chen B (2025) Characterization of T cells in the progression of dry eye disease using single-cell RNA sequencing in mice. Eur J Med Res 30:338.
https://doi.org/10.1186/s40001-025-02607-2